WADDP: Open for Innovation Our research is translational and focused on advancing technologies in Drug Delivery, Nanomedicine, Tissue Engineering, Regenerative Medicine, 3D-Bioprinting and Bio-Inspired Systems of the future.
WADDP: Open for Innovation Our research is translational and focused on advancing technologies in Drug Delivery, Nanomedicine, Tissue Engineering, Regenerative Medicine, 3D-Bioprinting and Bio-Inspired Systems of the future.
Start main page content

Our Research

World-Class > Collaborative > Responsive > Innovative > Impactful > Saving Lives

The WADDP is a team of highly passionate and skilled Pharmaceutical Scientists led by Professor Yahya Choonara innovating 21st-century patient-centric delivery systems for drugs and other bioactives.

We combine pharmaceutical design, nano-engineering, and translational science to develop medicines that are safer, smarter, and more effective.

By integrating our thematic pillars, WADDP advances Africa’s capacity for pharmaceutical innovation - from molecule design to market translation.

Our goal is to generate new knowledge while developing real-world therapeutic solutions that improve lives across the continent and beyond.

The team is obsessed with:

Answering Big Questions: High impact, unmet therapeutic needs, contextually relevant, globally applicable

Societal Relevance: Design safe, effective and cost-sensitive patient centric products

Critical Mass: Collaborative innovation, world-class labs, responsive and skilled pharmaceutical researchers 

Sustainability: Translational pharmaceutical sciences research

As the pathophysiology of infectious, lifestyle and hereditary diseases become clearer, the need for more targeted and personalised drug therapies become vital to improve the quality of life of patients.

Research at the WADDP plays an integral role in meeting this need through collaboration with Clinician Scientists and other experts focused on optimising the health and wellness of patients. The team is highly regarded for producing first-in-the-world technologies in multiple Thematic Areas that include:

  • Ultra-Fast Dissolving Matrices
  • Targeted Nanomedicines for Infectious Diseases and Cancers
  • Immunotherapeutic and Biomimetic Nanoparticles
  • Neuropharmaceutical Devices
  • Interventions for Neural Tissue Regeneration
  • Ocular Inserts for Drug/Bioactive Delivery
  • Rate-Modulated Vaginal Inserts for Single and/or Multiple Drugs
  • Oral Delivery of Proteins and Peptides
  • Targeted Anti-Thrombolytic Systems
  • Advanced Wound Healing Platforms
  • Chronotherapeutic Technologies
  • Gastroretentive Systems for NAW Molecules
  • Theranostics and ElectroActive Systems 
  • 3D-BioPrinting of Biomimetic Scaffolds
  • Stimuli-Responsive Biomaterials
  • Probiotics and Nutraceuticals
  • PharMATHaceutical Optimization  
  • Pharmaceutical Reformulation (Drug Re-puprosing)
 
Share